Dr Daniel Hodson
Dr Daniel Hodson is a Haematologist and was awarded the Gold Trainee Specialty Research Medal in 2011.
I began my haematology training in Cambridge in 2002. I quickly decided that understanding the biology of the normal lymphocyte counterpart to lymphoma might be a good place to start and was lucky enough to be awarded a CRUK clinical research training fellowship to join the lab of Dr Martin Turner at the Babraham Institute in Cambridge.
Here I completed a PhD in molecular immunology focused on the regulation gene expression in the development and activation of normal mouse lymphocytes.
After my PhD I returned briefly to clinical work and completed my CCT in haematology in 2010. My first real exposure to academic research was a success; I enjoyed it greatly and was awarded the Royal College of Pathologists Gold Research Medal.
My first real exposure to academic research was a success; I enjoyed it greatly and was awarded the Royal College of Pathologists Gold Research Medal.
Determined to continue my plan to work on the biology of lymphoid malignancy I then secured a Kay Kendall Leukaemia Fund intermediate fellowship to move to the National Institutes of Health, Bethesda USA to join the lab of Dr Lou Staudt.
I spent just over 4 years at the NIH working on the functional genomics of Diffuse Large B Cell Lymphoma and Burkitt Lymphoma. Whilst in the USA I applied for and was awarded a Medical Research Council Clinician Scientist Fellowship to return to Cambridge to start my own research group.
The main focus of this research will combine aspects of both my PhD and post-doc training and will investigate the mechanisms that corruption gene expression at the level of translation in aggressive B cell malignancies.